Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 487.00
Bid: 484.00
Ask: 490.00
Change: -6.00 (-1.22%)
Spread: 6.00 (1.24%)
Open: 493.00
High: 493.00
Low: 487.00
Prev. Close: 493.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Dividend Declaration and Share Buy-Back

16 Jan 2023 07:00

RNS Number : 7545M
B.P. Marsh & Partners PLC
16 January 2023
 

16 January 2023

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Interim Dividend Declaration

and

Share Buy-Back Programme

 

Interim Dividend

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, is pleased to declare an Interim Dividend of 1.39p per share covering the period from 1st February 2022 to 31st January 2023.

 

The Board has agreed that this year the dividend will be paid in two instalments: an Interim Dividend of 1.39p per share (£0.5m) in February 2023 and the balance in July 2023 as a Final Dividend, subject to Shareholder Approval at the Company's next Annual General Meeting, expected to be held in July 2023 (the "2023 AGM"). The Interim Dividend of 1.39p per share will be payable on 28th February 2023 to all Shareholders on the Register on 27th January 2023.

 

It remains the Company's aspiration to pay a dividend of at least £1.0m in aggregate for its year ending 31st January 2023, subject always to the Board's right to recommend an increased or decreased Final Dividend, for example in the event of significant realisations or capital commitments of the Company.

 

The Board will annually revisit the frequency of dividend payments for subsequent years as it reviews the cash requirements of the Group.

 

Share Buy-Back Programme

 

The Board is aware of the significant discount at which the Company's shares trade relative to its net asset value ("NAV") per share and remains committed to its previously stated objective to reduce this discount and enhance long term shareholder value. The Board believes that share buybacks are one of a number of appropriate means of achieving these objectives.

 

Accordingly, the Board has today approved a strategy to repurchase ordinary shares of 10.0p each in the Company ("Ordinary Shares") for up to a maximum aggregate consideration of £1.0m and subject to Ordinary Shares being available to purchase at a price representing a discount of at least 20% to the most recently announced NAV per share of 499.0p (the "Programme").

 

The Programme will be carried out in accordance with the Company's general authority to purchase a maximum of 3,746,600 Ordinary Shares, conferred by shareholders at the Company's Annual General Meeting held on 25th July 2022 (the "General Authority") and at a price not exceeding the maximum approved pursuant to the General Authority.

 

The purpose of the Programme is to reduce the Company's share capital outside of Treasury and it will commence on the date of this announcement and continue until either the maximum pecuniary amount has been purchased under the Programme or, if earlier, the expiration of the General Authority (which is in place until the 2023 AGM). The Programme will be financed through existing cash resources.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) (the "Regulation") and the delegated regulations made pursuant to it.

 

The purchased Ordinary Shares will be held by the Company in Treasury. Shares held in Treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Company confirms that it currently has no unpublished inside information.

 

The Company will announce any market purchase of Ordinary Shares pursuant to the authority without delay.

 

This announcement contains inside information.

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Stephen Jones / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUCAGUPWPGA
Date   Source Headline
18th Jul 20172:07 pmRNSInvestee Company Update - Nexus Underwriting
13th Jul 20175:10 pmRNSInvestee Company Update
5th Jul 20173:25 pmRNSDirector/PDMR Shareholding
30th Jun 201710:36 amRNSInvestee Company Update - Nexus Underwriting
29th Jun 20173:26 pmRNSShare Incentive Plan
28th Jun 20173:07 pmRNSNotice of AGM
19th Jun 20173:20 pmRNSInvestment
14th Jun 20173:55 pmRNSDirector/PDMR Shareholding
14th Jun 20172:56 pmRNSDirector/PDMR Shareholding
13th Jun 20171:10 pmRNSInvestment in North America
12th Jun 20174:01 pmRNSDirector/PDMR Shareholding
12th Jun 20173:56 pmRNSDirector/PDMR Shareholding
9th Jun 20177:05 amRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSFinal Results
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
24th Apr 20174:40 pmRNSChange of Registered Office
19th Apr 20175:40 pmRNSResult of General Meeting
12th Apr 20174:07 pmRNSBesso Disposal Update
6th Apr 20175:36 pmRNSDirector/PDMR Shareholding
5th Apr 201712:28 pmRNSPDMR Share Sale Plan
3rd Apr 201712:43 pmRNSDisposal and Notice of General Meeting
16th Mar 20174:50 pmRNSTransaction in Own Shares
15th Mar 20175:04 pmRNSShare Buy-Back Policy Update
15th Mar 20175:02 pmRNSDirector/PDMR Shareholding
15th Mar 20172:47 pmRNSTransaction in Own Shares
14th Mar 20172:16 pmRNSTransaction in Own Shares
13th Mar 20173:56 pmRNSTransaction in Own Shares
10th Mar 20176:18 pmRNSTransaction in Own Shares
3rd Mar 20173:23 pmRNSTransaction in Own Shares
3rd Mar 20173:21 pmRNSDirector/PDMR Shareholding
3rd Mar 201711:12 amRNSShare Buy-Back Policy
28th Feb 20174:17 pmRNSDisposal
17th Feb 20174:36 pmRNSInvestment
7th Feb 20177:00 amRNSTrading Update
3rd Feb 201712:30 pmRNSDirector/PDMR Shareholding
30th Jan 20177:40 amRNSInvestment
10th Jan 20171:43 pmRNSDirector/PDMR Shareholding
5th Jan 20172:46 pmRNSPortfolio Update
4th Jan 20177:00 amRNSDisposal
15th Dec 20163:55 pmRNSFurther Investment in Nexus
22nd Nov 20163:45 pmRNSInvestment
18th Oct 20167:00 amRNSInterim Results
8th Sep 20167:00 amRNSTrading Update
26th Jul 20167:00 amRNSInvestee Company update
20th Jul 20165:07 pmRNSResult of AGM
5th Jul 20166:20 pmRNSDirector/PDMR Shareholding
1st Jul 201610:52 amRNSDividend Declaration
28th Jun 20164:41 pmRNSResponse to EU Referendum Result
28th Jun 20164:39 pmRNSShare Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.